肝脏代谢酶活动与内源性物质的现状,挑战和局限性
Current drug metabolism
|August 20, 2024
概括
精确的剂量要求对药物代谢进行客观测量. 监测的内源生物标志物可以动态评估酶活性,从而实现个性化药物治疗和减少药物不良反应.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
- 临床医学 临床医学
背景情况:
- 精确的剂量对药物的有效性和安全性至关重要,特别是在肝功能受损的患者中.
- 目前的方法缺乏客观的指数来直接评估药物代谢能力.
- 影响药物暴露的酶活性受遗传学,药物相互作用和生理状态的影响.
研究的目的:
- 审查内源性物质在精确剂量管理中的作用.
- 探索影响药物代谢酶活性的因素.
- 讨论内源生物标志物对于动态药物暴露评估的潜力.
主要方法:
- 关于内源生物标志物和药物代谢的最新科学文献的综述.
- 对支持使用替代探针,如6β-基皮质醇/皮质醇等临床数据的分析.
- 在体内检查影响酶活性和药物暴露的因素.
主要成果:
- 内源基质,如6β-基皮质醇 (6β-OH-皮质醇) /皮质醇,显示出作为酶活性替代探针的希望.
- 监测一组内源生物标志物的小组可以提供对药物代谢的动态见解.
- 这些生物标志物可以帮助解决在临床前阶段药物代谢的不确定性.
结论:
- 内生生物标志物提供了一种可行的方法来动态量化酶活动.
- 这种方法有可能显著提升精确剂量策略.
- 进一步的研究可以完善这些生物标志物的使用,以改善患者的治疗结果.
更多相关视频
08:39Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
8.0K
08:36Metabolic Mapping: Quantitative Enzyme Cytochemistry and Histochemistry to Determine the Activity of Dehydrogenases in Cells and Tissues
Published on: May 26, 2018
11.8K
相关概念视频
Liver Physiology
461
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
461
Factors Affecting Drug Biotransformation: Biological
128
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
128
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
98
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
98
Regulation of Metabolism
9.3K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.3K
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Drug Metabolism: Phase I Reactions
3.2K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.2K
